The Programmed Death-1 Ligand 1:B7-1 Pathway Restrains Diabetogenic Effector T Cells In VivoAlison M. Paterson, Arlene H. Sharpe, Vijay K. Vanguri et al.|The Journal of Immunology|2011Cited by 205
The Novel Costimulatory Programmed Death Ligand 1/B7.1 Pathway Is Functional in Inhibiting Alloimmune Responses In VivoMohamed H. Sayegh, Leonardo V. Riella, Susanne Chock et al.|The Journal of Immunology|2011Cited by 133